Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kaufman, Dan S  [Clear All Filters]
2023
Xue D, Lu S, Zhang H, Zhang L, Dai Z, Kaufman DS, Zhang J. Induced pluripotent stem cell-derived engineered T cells, natural killer cells, macrophages, and dendritic cells in immunotherapy. Trends Biotechnol. 2023.
2020
Zhu H, Blum RH, Bernareggi D, Ask EHeggernes, Wu ZM, Hoel HJulie, Meng Z, Wu C, Guan K-L, Malmberg K-J, et al. Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. Cell Stem Cell. 2020.
2019
Bernarreggi D, Pouyanfard S, Kaufman DS. Development of innate immune cells from human pluripotent stem cells. Exp Hematol. 2019.
Zhu H, Blum R, Bjordahl R, Gaidarova S, Rogers P, Lee TTong, Abujarour R, Bonello GB, Wu J, Tsai P-F, et al. Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity. Blood. 2019.
2016
Kidwai F, Edwards J, Zou L, Kaufman DS. Fibrinogen Induces RUNX2 Activity and Osteogenic Development from Human Pluripotent Stem Cells. Stem Cells. 2016.
2015
Song W, Kaufman DS, Shen W. Efficient generation of endothelial cells from human pluripotent stem cells and characterization of their functional properties. J Biomed Mater Res A. 2015.
Angelos MG, Kaufman DS. Pluripotent stem cell applications for regenerative medicine. Curr Opin Organ Transplant. 2015;20(6):663-670.
2014
Ferrell PI, Xi J, Ma C, Adlakha M, Kaufman DS. The RUNX1 +24 Enhancer and P1 Promoter Identify a Unique Subpopulation of Hematopoietic Progenitor Cells Derived from Human Pluripotent Stem Cells. Stem Cells. 2014.